Identification |
Name: | 2-Butenoic acid,3-[3-hydroxy-4-(hydroxymethyl)-8-methoxy-9-methyl-6-[(1E)-1-methyl-1-propen-1-yl]-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-1-yl]-,(2E)- |
Synonyms: | 2-Butenoicacid,3-[3-hydroxy-4-(hydroxymethyl)-8-methoxy-9-methyl-6-(1-methyl-1-propenyl)-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-1-yl]-,(E,E)-; 2-Butenoic acid,3-[3-hydroxy-4-(hydroxymethyl)-8-methoxy-9-methyl-6-[(1E)-1-methyl-1-propenyl]-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-1-yl]-,(2E)- (9CI); 11H-Dibenzo[b,e][1,4]dioxepin, 2-butenoic acid deriv.; AuranticinA |
CAS: | 133943-50-7 |
Molecular Formula: | C24H24 O8 |
Molecular Weight: | 0 |
InChI: | InChI=1/C24H24O8/c1-6-11(2)15-9-18(30-5)13(4)21-23(15)31-22-16(10-25)17(26)8-14(12(3)7-19(27)28)20(22)24(29)32-21/h6-9,25-26H,10H2,1-5H3,(H,27,28)/b11-6+,12-7+ |
Molecular Structure: |
|
Properties |
Flash Point: | 233°C |
Boiling Point: | 677.4°Cat760mmHg |
Density: | 1.329g/cm3 |
Refractive index: | 1.623 |
Flash Point: | 233°C |
Safety Data |
|
|